Chemoinformaics analysis of 16beta,17-Dihydroxy-ent-kaurane-19-oic acid
| Molecular Weight | 336.472 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 20 |
| Exact Molecular Weight | 336.23 | nRing | 4 |
| Solubility: LogS | -3.203 | nHRing | 0 |
| Solubility: LogP | 2.68 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.9454 |
| nHD | 3 | BPOL | 32.9706 |
| QED | 0.723 |
| Synth | 5.644 |
| Natural Product Likeliness | 3.343 |
| NR-PPAR-gamma | 0.571 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.029 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -5.357 |
| MDCK | 0.0000179 |
| BBB | 0.467 |
| PPB | 0.918322 |
| VDSS | 0.647 |
| FU | 0.0868823 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.732 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.767 |
| CYP2c9-inh | 0.053 |
| CYP2c9-sub | 0.128 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.168 |
| CYP3a4-inh | 0.178 |
| CYP3a4-sub | 0.059 |
| CL | 1.962 |
| T12 | 0.339 |
| hERG | 0.008 |
| Ames | 0.014 |
| ROA | 0.034 |
| SkinSen | 0.046 |
| Carcinogencity | 0.051 |
| EI | 0.095 |
| Respiratory | 0.686 |
| NR-Aromatase | 0.856 |
| Antiviral | Yes |
| Prediction | 0.638014 |